2023. Adjuvant therapy with nivolumab versus placebo in patients with resected stage IIB/C melanoma (CheckMate 76K). SKIN The Journal of Cutaneous Medicine. 7, 2 (Mar. 2023), s163. DOI:https://doi.org/10.25251/skin.7.supp.163.